Biology of Blood and Marrow Transplantation
Volume 13, Issue 7 , Pages 771-777 , July 2007

Invasive Fungal Infection Following Reduced-Intensity Cord Blood Transplantation for Adult Patients with Hematologic Diseases

  • Shigesaburo Miyakoshi

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Eiji Kusumi

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Tomoko Matsumura

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Akiko Hori

      Affiliations

    • Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Naoko Murashige

      Affiliations

    • Hematopoietic Stem Cell Transplantation Unit, National Cancer Center Hospital, Tokyo, Japan
    • ,
  • Tamae Hamaki

      Affiliations

    • Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Koichiro Yuji

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Naoyuki Uchida

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Kazuhiro Masuoka

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Atsushi Wake

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Yoshinobu Kanda

      Affiliations

    • Department of Cell Therapy and Transplantation Medicine, University of Tokyo Hospital, Tokyo, Japan
    • ,
  • Masahiro Kami

      Affiliations

    • Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • ,
  • Yuji Tanaka

      Affiliations

    • Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan
    • Corresponding Author InformationCorrespondence and reprint requests: Yuji Tanaka, M.D., Division of Exploratory Research, the Institute of Medical Science, the University of Tokyo, Tokyo 1088639 Japan.
    • ,
  • Shuichi Taniguchi

      Affiliations

    • Department of Hematology, Toranomon Hospital, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan

Received 13 November 2006 ,Accepted 23 February 2007.

References 

  1. Gluckman E. Hematopoietic stem-cell transplants using umbilical-cord blood. N Engl J Med. 2001;344:1860–1861
  2. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565–1577
  3. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–2285
  4. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351:2265–2275
  5. Barker JN, Weisdorf DJ, DeFor TE, Blazar BR, Miller JS, Wagner JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood. 2003;102:1915–1919
  6. Miyakoshi S, Yuji K, Kami M, et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res. 2004;10:3586–3592
  7. Saavedra S, Sanz GF, Jarque I, et al. Early infections in adult patients undergoing unrelated donor cord blood transplantation. Bone Marrow Transplant. 2002;30:937–943
  8. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358–4366
  9. Kojima R, Kami M, Nannya Y, et al. Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen. Biol Blood Marrow Transplant. 2004;10:645–652
  10. Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062–2068
  11. Hiraoka A, Ohashi Y, Okamoto S, et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001;28:181–185
  12. Ratanatharathorn V, Nash RA, Przepiorka D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303–2314
  13. Kishi Y, Kami M, Miyakoshi S, et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation. 2005;80:34–40
  14. Hughes WT, Armstrong D, Bodey GP, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730–751
  15. Kami M, Tanaka Y, Kanda Y, et al. Computed tomographic scan of the chest, latex agglutination test and plasma (1-3)-beta-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica. 2000;85:745–752
  16. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7–14
  17. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706
  18. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002;34:909–917
  19. Fukuda T, Boeckh M, Carter RA, et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 2003;102:827–833
  20. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis. 1995;20:115–125
  21. Sakiyama M, Kami M, Hori A, et al. Regimen-related toxicity following reduced-intensity stem-cell transplantation (RIST): comparison between Seattle criteria and National Cancer Center Common Toxicity Criteria (NCI-CTC) version 2.0. Bone Marrow Transplant. 2004;34:787–794
  22. Kojima R, Tateishi U, Kami M, et al. Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005;11:506–511
  23. Martino R, Parody R, Fukuda T, et al. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: a retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood. 2006;108:2928–2936
  24. Einsele H, Quabeck K, Muller KD, et al. Prediction of invasive pulmonary aspergillosis from colonisation of lower respiratory tract before marrow transplantation [letter]. Lancet. 1998;352:1443
  25. Kami M, Fukui T, Ogawa S, et al. Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis. 2001;33:1504–1512
  26. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood. 2001;97:1604–1610
  27. Narimatsu H, Matsumura T, Kami M, et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant. 2005;11:429–436
  28. Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood. 2002;100:4521–4528
  29. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis. 1997;175:1459–1466
  30. Kami M, Machida U, Okuzumi K, et al. Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy. Br J Haematol. 2002;117:40–46

PII: S1083-8791(07)00188-7

doi: 10.1016/j.bbmt.2007.02.012

Biology of Blood and Marrow Transplantation
Volume 13, Issue 7 , Pages 771-777 , July 2007

Article Tools

* Image Usage & Resolution